All questions
Dosing and administration: Entyvio (vedolizumab) in ulcerative colitis
10 questions · 3 sources
Questions that apply to every indication of Entyvio are on Entyvio (vedolizumab), all indications.
Premedication
Was premedication used for Entyvio infusion reactions in clinical trials?
Applies to Moderately to severely active ulcerative colitis in adults, intravenous induction and maintenance
Treatment combinations
Can Entyvio be used with steroids or immunomodulators?
Dosing
What is the Entyvio dosing schedule for ulcerative colitis?
Is Entyvio IV every 4 weeks more effective than every 8 weeks?
Applies to Moderately to severely active ulcerative colitis in adults, intravenous induction and maintenance
Note: This result is from the ulcerative colitis maintenance trial (UC Trial II).
What should be done if an Entyvio Pen dose is missed?
Applies to Moderately to severely active ulcerative colitis in adults, subcutaneous maintenance after two intravenous induction doses
Switching
Can patients switch from Entyvio IV to the Entyvio Pen?
Applies to Moderately to severely active ulcerative colitis in adults, subcutaneous maintenance after two intravenous induction doses
Administration
How long does an Entyvio IV infusion take?
Applies to Moderately to severely active ulcerative colitis in adults, intravenous induction and maintenance
Can patients inject the Entyvio Pen themselves at home?
Applies to Moderately to severely active ulcerative colitis in adults, subcutaneous maintenance after two intravenous induction doses
Where should the Entyvio Pen be injected?
Applies to Moderately to severely active ulcerative colitis in adults, subcutaneous maintenance after two intravenous induction doses
Preparation
How is Entyvio IV reconstituted and diluted?
Applies to Moderately to severely active ulcerative colitis in adults, intravenous induction and maintenance
“Reconstitution Instructions
1. Remove the flip-off cap from the single-dose vial and wipe with alcohol swab.
Reconstitute ENTYVIO vial containing lyophilized powder with 4.8 mL of Sterile
Water for injection, 0.9% Sodium Chloride Injection, or Lactated Ringer’s Injection,
at room temperature (20°C to 25°C [68°F to 77°F]), using a syringe with a 21- to
25-gauge needle.
2. Insert the syringe needle into the vial through the center of the stopper and direct the
stream of Sterile Water for Injection, 0.9% Sodium Chloride Injection, or Lactated
Ringer’s Injection, to the glass wall of the vial to avoid excessive foaming.
3. Gently swirl the vial for at least 15 seconds to dissolve the lyophilized powder.
Do not vigorously shake or invert.
4. Allow the solution to sit for up to 20 minutes at room temperature to allow for
reconstitution and for any foam to settle; the vial can be swirled and inspected for
dissolution during this time. If not fully dissolved after 20 minutes, allow another
10 minutes for dissolution. Do not use the vial if the drug product is not dissolved
within 30 minutes.
5. Visually inspect the reconstituted ENTYVIO solution for particulate matter and
discoloration prior to dilution. Solution should be clear or opalescent, colorless
to light brownish yellow and free of visible particulates. Do not administer
reconstituted solution showing uncharacteristic color or containing particulates.
6. Once dissolved, gently invert vial three times.
7. Immediately, withdraw 5 mL (300 mg) of reconstituted ENTYVIO solution using
a syringe with a 21- to 25-gauge needle. Discard any remaining portion of the
reconstituted solution in the vial.
Dilution Instructions
Add the 5 mL (300 mg) of reconstituted ENTYVIO solution to 250 mL of 0.9% Sodium
Chloride Injection, or Lactated Ringer’s Injection, and gently mix the infusion bag. Do not
add other medicinal products to the prepared infusion solution or intravenous infusion set.
Once reconstituted and diluted, use the infusion solution as soon as possible.
Discard any unused portion of the infusion solution.” (opens the source at this quote in a new tab)